DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID versus placebo, at three months, from a single ...
“Our findings indicate that the vaccine provided a significant enhanced level of protection against these infections in the ...
A new analysis of clinical trial data indicates that psilocybin-assisted psychotherapy provides immediate relief for anxiety ...
Janus kinase (JAK) inhibitors, including baricitinib, block cytokine signaling and are effective disease-modifying treatments for several autoimmune diseases. Whether baricitinib preserves β-cell ...
Andrew Nixon, spokesman for Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., announced on Thursday that moving forward, “all new vaccines will undergo safety testing in ...
US Health and Human Services Secretary Robert F. Kennedy Jr. has repeatedly claimed in public statements that most vaccines recommended for children in the US have not been tested against placebos, ...
Individuals with a rare form of epilepsy treated with fenfluramine experienced significantly greater seizure reduction as ...